前列腺特异抗原

qián liè xiàn tè yì kàng yuán
  • prostate-specific antigen
前列腺特异抗原前列腺特异抗原
  1. 目的:研究前列腺特异抗原(PSA)是否可作为女性高雄激素症诊断的标志。

    Objective : To determine whether the increased level of serum prostate-specific antigen ( PSA ) could be used as a diagnostic marker of hyperandrogenism in women .

  2. 前列腺特异抗原基因启动子中二个与雄激素调节相关的序列

    Two Androgen-related Regulatory Sequences in the Promoter Region of Prostate-Specific Antigen Gene

  3. 目的:探讨慢性前列腺炎与前列腺特异抗原(PSA)的关系。

    Purpose : To study the relationship between chronic prostatitis and PSA .

  4. 人前列腺特异抗原(PSA)基因特异地在前列腺上皮细胞中表达。且受雄激素调节。

    Human prostate - specific antigen .

  5. 抗前列腺特异抗原/抗CD3双特异性单链抗体四聚体的活性研究

    Biological activity of tetramer of bispecific single-chain antibody against human prostate-specific antigen and CD3 molecule

  6. 目的研究姜黄素对前列腺特异抗原(PSA)表达的影响。

    Aim To study the effect of curcumin on the expression of prostate specific antigen ( PSA ) .

  7. 目的分析前列腺特异抗原(PSA)不同评价结果与前列腺癌的关系。

    Objective To analyze the relationship between prostate cancer and multi estimating results of prostate specific antigen ( PSA ) .

  8. 方法:对27例晚期PCa患者在行双侧睾丸切除术后行10%鸦胆子油乳等治疗,并动态检测前列腺特异抗原(PSA)和性激素水平,观察临床表现的变化。

    Methods : Dynamic observation of serum PSA and sexual hormone level changes and clinical characteristics in 27 patients with advanced prostate cancer .

  9. 目的:探讨检测骨髓前列腺特异抗原(PSA)筛选前列腺癌骨转移的价值。

    Objective To investigate the clinical diagnostic value of bone marrow prostate specific antigen ( PSA ) in bone metastasis of prostatic cancer .

  10. 目的:检测精液中前列腺特异抗原(prostatespecialantigen,PSA)与纤维连接蛋白(fi-bronectin,FN)含量,分析其相关性,以探讨其对精液液化的影响。

    Objective : To discuss the effect of prostate special antigen ( PSA ) and fibronectin ( FN ) in liquefying semen .

  11. 目的:探讨前列腺特异抗原(PSA)、发射型计算机断层扫描(ECT)骨显像诊断前列腺癌骨转移的临床价值。

    Objectives : To evaluate the clinical significance of PSA and ECT bone scans in the diagnosis of bone metastasis in prostate cancer patients .

  12. 目的:研究抗前列腺特异抗原(PSA)/抗CD3双特异性单链抗体四聚体的生物活性。

    AIM : To study the biological activity of tetramer of bispecific single-chain antibody against human prostate-specific antigen ( PSA ) and CD3 molecule .

  13. 抗前列腺特异抗原/抗人CD3双特异性单链抗体基因在HeLa细胞中的表达及亲和活性测定

    Expression of bispecific single chain Fv antibody gene against human prostate specific antigen and CD3 molecule in HeLa cells and its identification of binding affinity

  14. 目的分析经直肠超声(TRUS)和前列腺特异抗原(PSA)在前列腺癌穿刺活检中的作用,提出各种穿刺方式适用的条件,以求在减少穿刺并发症的前提下获得较高的阳性结果。

    Objective To evaluate the role of TRUS and PSA in the prostate biopsy and suggest the selection of different biopsy method .

  15. 目的构建可在体外应用荧光共振能量转移(FRET)技术检测具有酶活性的前列腺特异抗原(PSA)的生物检测器。

    AIM To construct a fluorescence resonance energy transfer ( FRET ) - based biosensor for detecting the enzymatically active prostate-specific antigen ( PSA ) .

  16. 前列腺特异抗原(PSA)筛查和直肠指检对于前列腺癌死亡率的影响尚无结论。

    Background The effect of screening with prostate-specific – antigen ( PSA ) testing and digital rectal examination on the rate of death from prostate cancer is unknown .

  17. 研究前列腺特异抗原在乳腺癌组织中的表达及其与ER、PR表达的关系。

    Purpose : To investigate the expression of prostatic specific antigen ( PSA ), estrogen receptor ( ER ) and progesterone receptor ( PR ) in human breast cancer and their correlation .

  18. 方法:对48例精液迟缓液化症患者和30例精液液化正常者分别测定其精液前列腺特异抗原(PSA)含量;

    Methods : The content of semen PSA was measured in 48 patients with the symptom of semen delayed liquefaction and 30 cases with normal Liquefaction of the semen .

  19. 前列腺特异抗原(PSA)是前列腺和前列腺癌细胞产生的蛋白质,是用来追踪治疗效果和预测前列腺癌发展趋势的指标。

    PSA is a protein produced by prostate and prostate cancer cells , and is used to track the effectiveness of treatment and the possible progression of prostate cancer .

  20. 治疗后,治疗组血清前列腺特异抗原(PSA)水平下降与对照组比较更为明显,差异有统计学意义(p0.05)。

    After treatment , treatment of groups of serum prostate-specific antigen ( PSA ) levels decline compared with the control group is even more apparent , the difference statistically significant ( p0.05 ) .

  21. 为了探讨血清前列腺特异抗原(PSA)的随龄变化,用ABC-ELISA检测了100例前列腺正常的男性血清PSA的浓度。

    To discuss the changes of prostate specific antigen ( PSA ) following age , the serum concentrations of PSA were measured by ABC ELISA in 100 men with normal prostate gland .

  22. 目的探讨化学发光法(CLIA)测定前列腺特异抗原(PSA)及游离前列腺特异抗原(fPSA)在诊断前列腺疾病中的准确性及其意义。

    Objective To explore the precision and significance of CLIA for detecting the serum PSA and fPSA in diagnosing prostate diseases .

  23. 我们分析、比较了骨源性碱性磷酸酶(BAP)和前列腺特异抗原(PSA)对前列腺癌骨转移的诊断意义,并探讨了二者在前列腺癌骨转移分级中的应用价值。

    The diagnosis value of BAP and PSA in prostate cancer with bone metastases was studied and its application in the classification of bone metastases was investigated .

  24. 人前列腺特异抗原(hPSA)的纯化及放射免疫分析的建立

    Purification of Human Prostate Specific Antigen ( hPSA ) and Development of Radioimmunoassay for hPSA

  25. 作者建立了血清前列腺特异抗原(PSA)的生物素-亲和素酶联免疫(BA-ELISA)测定法并用于临床。

    Serum prostate specific antigen ( PSA ) - the biotin-avidin enzym immunoassay ( BA-ELISA ) was established and used in clinical practice .

  26. 在过去l0年,用PSA(前列腺特异抗原)进行检测已成为发现早期前列腺肿瘤的常规手段。

    In the past decade , screening with the PSA ( prostate-specific antigen ) test has become a routine tool for the early detection of prostate tumors .

  27. 目的扩增出抗前列腺特异抗原(PSA)单克隆抗体(MAb)的重链可变区(VH)单域抗体基因,并在大肠杆菌中表达。

    AIM To amplify the V H single domain gene of anti prostate specific antigen ( PSA ) monoclonal antibody ( mAb ), and express it in E. coli .

  28. 目的:构建抗人前列腺特异抗原(PSA)单链抗体(scFv)/人p53四聚功能域融合基因,并进行真核表达和活性测定。

    Objective : To construct anti human prostate specific antigen ( PSA ) single chain Fv antibody ( scFv ) / human p53 tetramerization domain fusion gene and express fusion protein in HeLa cells .

  29. 目的研究血清游离前列腺特异抗原(FPSA)与总前列腺特异抗原(TPSA)比值对前列腺癌患者的诊断价值。

    Objective To investigate the diagnostic value of free prostate specific antigen ( FPSA ) / total prostate specific antigen ( TPSA ) in prostate cancer .

  30. 目的探讨不同血清前列腺特异抗原(PSA)水平前列腺癌检出情况以及直肠指诊(DRE)、经直肠超声检查(TRUS)、PSA密度(PSAD)等指标对筛查前列腺穿刺活检病例的意义。

    Objective To evaluate the detection of prostate cancer in different prostate specific antigen ( PSA ) level and the predict value of PSA , digital rectal examination ( DRE ), transrectal ultrasound scan ( TRUS ) and PSA density ( PSAD ) .